Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Thyroid Hormone Receptor alpha ELISA Kit (AC2951)
Cat.#: ASET-1540
Specifications
Description Human Thyroid Hormone Receptor alpha ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Thyroid Hormone Receptor alpha concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.01 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-2457 Human Neurofascin ELISA Kit (AC3868) Quantitative inquiry ASET-1295 Human NPFF2 Receptor ELISA Kit (AC2706) Quantitative inquiry ASET-1932 Human ADAM17 ELISA Kit (AC3343) Quantitative inquiry ASET-1208 Mouse Adiponectin ELISA Kit (AC2619) Quantitative inquiry ASET-2383 Human VIP ELISA Kit (AC3794) Quantitative inquiry ASET-2155 Rat MAdCAM1 ELISA Kit (AC3566) Quantitative inquiry ASET-1641 Human LRRK2 ELISA Kit (AC3052) Quantitative inquiry ASET-2055 Mouse Glutamine Synthetase ELISA Kit (AC3466) Quantitative inquiry ASET-1041 Mouse CORT ELISA Kit (AC2452) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket